normal coronary arteries and a heart biopsy revealed myocardial interstitial fibrosis compatible with druginduced cardiomyopathy (Fig. 1a) . Appropriate hemodialysis management improved his cardiac symptoms and increased his LVEF to 0.48. Because his cardiac function after hemodialysis was the same as that observed five years before, we believed that he would tolerate kidney transplantation surgery. Six months after admission, he underwent a living-related renal transplantation and produced urine soon after the transplantation. His LV function improved as his LVEF increased to 0.6, which has been maintained along with a favorable renal allograft function for four years (Fig. 1b) .
Early-onset AIC, which occurs during the year after the completion of chemotherapy, is largely irreversible [3] . However, it has been reported that late-onset AIC can be reversed in almost two-thirds of cases [4] . The exact factors responsible for AIC irreversibility are unknown.
It is widely accepted that the heart and kidney are affected by each other, and chronic kidney disease may also cause heart failure in the absence of coronary artery disease. Uremic cardiomyopathy is expressed as LV dilatation and systolic dysfunction. Although the uremic toxins are not yet to be clearly determined, the uremic milieu can affect myocardial contractility and function. It has been shown that LV function improves after successful kidney transplantations [5] . We presume that the main reason for the improvement in LV function in our patient was recovery from the uremic milieu associated with AIC, and this recovery from the uremic state helped to stop the progression of AIC itself.
The present case indicates that kidney transplantation can be safely performed in a dialysis patient with AIC, and that successful kidney transplantation may even help to prevent aggravation of LV function. Fig. 1 a A heart 
